People
“Hopefully the approval process will go very quickly, and we think we have a winner here,” Trump told White House reporters on Wednesday.
According to the report, the options are worth $101 million and do not hinge on the clinical success of the vaccine program.
Two Chinese nationals have been indicted for hacking into the computer systems of hundreds of companies, governments, non-governmental organizations and more to steal trade secrets, including data on treatments related to COVID-19.
In an ongoing online hearing before the House Committee on Energy and Commerce’s Oversight and Investigation subcommittee, executives from across the pharmaceutical industry outlined the steps their companies are taking to combat COVID-19 and restore the world to a sense of normalcy.
Rebecca Vaught never set out to become an entrepreneur, but that’s exactly what happened when she launched Van Heron Labs earlier this year with a goal of reframing the understanding of the body’s organismal and cellular performance.
Oxford University, which by many standards is ahead of everyone in the vaccine development world, is suggesting end of the year is possible, but being very cautious about it.
The trial was initially scheduled for July, but in April had been postponed until October due to the pandemic. A final decision will be made in August.
The trendy drug brand names for 2020 include Tepezza®, Zolgensma®, and Qvar®. Like the names of newborn children, they are designed to be visually distinctive and to make a statement.
Biopharma and life sciences companies bolster their leadership teams and board with these Movers & Shakers.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 17, 2020.
PRESS RELEASES